Phase I/II trial of Arginine Butyrate and ganciclovir in Epstein-Barr virus-associated lymphoid malignancies.

被引：0
|
作者：
Faller, D. V.
Hermine, O.
Small, T.
Suarez, F.
O'Reilly, R.
Boulad, F.
Fingeroth, J.
Mentzer, S. J.
Klein, C.
Horwitz, S.
Perrine, S. P.
机构：
[1] Boston Univ, Sch Med, Boston, MA 02215 USA
[2] Hop Necker Enfants Malad, Paris, France
[3] Mem Sloan Kettering Canc Ctr, New York, NY USA
[4] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[5] Brigham & Womens Hosp, Boston, MA 02115 USA
[6] Childrens Hosp, Hannover, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：432S / 432S
页数：1
相关论文
共 50 条
  • [1] A Phase I/II study of Arginine Butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies
    Perrine, SP
    Hermine, O
    Mentzer, SJ
    Small, TN
    Horwitz, SM
    Fingeroth, J
    Boulad, F
    Di Nicola, M
    Klein, C
    O'Reilly, R
    Levy, A
    Faller, DV
    BLOOD, 2004, 104 (11) : 176A - 176A
  • [2] Arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies
    不详
    CLINICAL LYMPHOMA, 2004, 5 (03): : 146 - 147
  • [3] A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies
    Perrine, Susan R.
    Hermine, Olivier
    Small, Trudy
    Suarez, Felipe
    O'Reilly, Richard
    Boulad, Farid
    Fingeroth, Joyce
    Askin, Melissa
    Levy, Arthur
    Mentzer, Steven J.
    Di Nicola, Massimo
    Gianni, Alessandro M.
    Klein, Christoph
    Horwitz, Steven
    Faller, Douglas V.
    BLOOD, 2007, 109 (06) : 2571 - 2578
  • [4] EPSTEIN-BARR VIRUS-ASSOCIATED MALIGNANCIES
    RICHTSMEIER, WJ
    WITTELS, EG
    MAZUR, EM
    CRC CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 1987, 25 (02): : 105 - 136
  • [5] The Microenvironment in Epstein-Barr Virus-Associated Malignancies
    Tan, Geok Wee
    Visser, Lydia
    Tan, Lu Ping
    van den Berg, Anke
    Diepstra, Arjan
    PATHOGENS, 2018, 7 (02)
  • [6] IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-ASSOCIATED MALIGNANCIES
    Long, Heather M.
    Parsonage, Gregory
    Fox, Christopher P.
    Lee, Steven P.
    DRUG NEWS & PERSPECTIVES, 2010, 23 (04) : 221 - 228
  • [7] EPSTEIN-BARR VIRUS-ASSOCIATED LYMPHOID MALIGNANCIES: THE EXPANDING SPECTRUM OF HEMATOPOIETIC NEOPLASMS
    Kimura, Hiroshi
    Kawada, Jun-Ichi
    Ito, Yoshinori
    NAGOYA JOURNAL OF MEDICAL SCIENCE, 2013, 75 (3-4): : 169 - 179
  • [8] Arginine butyrate-induced susceptibility to ganciclovir in an Epstein-Barr virus (EBV)-associated lymphoma
    Mentzer, SJ
    Fingeroth, J
    Reilly, JJ
    Perrine, SP
    Faller, DV
    BLOOD CELLS MOLECULES AND DISEASES, 1998, 24 (08) : 114 - 123
  • [9] A Review of the Cytomorphology of Epstein-Barr Virus-Associated Malignancies
    Michelow, Pam
    Wright, Colleen
    Pantanowitz, Liron
    ACTA CYTOLOGICA, 2012, 56 (01) : 1 - 14
  • [10] Molecular Genetics in Epstein-Barr Virus-Associated Malignancies
    Umakanthan, Srikanth
    Bukelo, Maryann M.
    LIFE-BASEL, 2021, 11 (07):
12345